Trial NCT04790786
Publication OPTIMISE-C19 - Huang D, JAMA Netw Open (2022) (published paper)
Primary outcome on the report: Hospital-free days up to day 28 after mAb treatment. This outcome was an ordinal end point, with death as the worst outcome (labeled as −1) followed by the length of time alive and free of hospitalization, such that the best outcome would be 28 hospital-free days. If a patient had intervening days free of hospitalization and was then rehospitalized, the patient was given credit for the intervening days as free of hospitalization.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.